Last reviewed · How we verify

NCT06982690

Anesthesia Modality and Oncologic Outcomes in High-Risk NMIBC: A Randomized Trial

Not yet recruiting NA Last updated 21 May 2025
What this trial tests

NA trial testing Spinal Anesthesia in NMIBC in 370 participants. Not yet recruiting.

Timeline
1 August 2025
Primary endpoint
30 November 2029
30 November 2029

Quick facts

Lead sponsorNational Taiwan University Hospital
PhaseNA
StatusNot yet recruiting
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingsingle
Primary purposetreatment
Enrollment370
Start date1 August 2025
Primary completion30 November 2029
Estimated completion30 November 2029
Sites1 location across Taiwan

Drugs / interventions tested

Conditions studied

Sponsor

National Taiwan University Hospital

Who can join

Adults 20 to 80, any sex, with NMIBC or TURBT. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

To demonstrate the superior efficacy of spinal anesthesia (SA) versus general anesthesia (GA) according to the delay of time to recurrence in high-risk NMIBC patients up to Week 104 after TURBT.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. Comparison of spinal versus general anaesthesia in high-risk non-muscle invasive bladder cancer: study protocol for a randomised controlled trial.
    Fang CW, Shau WY, Fan SZ, Chueh JS. · · 2025 · PMID 41314851 · DOI 10.1136/bmjopen-2025-107824

Verify or expand the search:

Other trials of Spinal Anesthesia

Trials testing the same drug.

Other recruiting trials for NMIBC

Currently open trials in the same condition.

Other National Taiwan University Hospital trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06982690.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing